Milestone Pharmaceuticals...

1.26
0.10 (8.62%)
At close: Apr 24, 2025, 3:59 PM
1.25
-0.44%
After-hours: Apr 24, 2025, 07:46 PM EDT

Milestone Pharmaceuticals Statistics

Share Statistics

Milestone Pharmaceuticals has 53.35M shares outstanding. The number of shares has increased by 0.18% in one year.

Shares Outstanding 53.35M
Shares Change (YoY) 0.18%
Shares Change (QoQ) 0.05%
Owned by Institutions (%) 37.09%
Shares Floating 50.79M
Failed to Deliver (FTD) Shares 80.66K
FTD / Avg. Volume 3.25%

Short Selling Information

The latest short interest is 2.56M, so 4.8% of the outstanding shares have been sold short.

Short Interest 2.56M
Short % of Shares Out 4.8%
Short % of Float 4.84%
Short Ratio (days to cover) 1

Valuation Ratios

The PE ratio is 0 and the forward PE ratio is -0.88. Milestone Pharmaceuticals's PEG ratio is 0.

PE Ratio 0
Forward PE -0.88
PS Ratio 0
Forward PS 0.2
PB Ratio 11.17
P/FCF Ratio -5.09
PEG Ratio 0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Milestone Pharmaceuticals.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 9.1, with a Debt / Equity ratio of 4.17.

Current Ratio 9.1
Quick Ratio 9.1
Debt / Equity 4.17
Debt / EBITDA -1.3
Debt / FCF -1.9
Interest Coverage 11.76

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $0
Employee Count 33
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -20.25% in the last 52 weeks. The beta is 1.38, so Milestone Pharmaceuticals's price volatility has been higher than the market average.

Beta 1.38
52-Week Price Change -20.25%
50-Day Moving Average 1.56
200-Day Moving Average 1.65
Relative Strength Index (RSI) 53.44
Average Volume (20 Days) 2.48M

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -42.1M
Net Income 0
EBITDA -42.1M
EBIT n/a
Earnings Per Share (EPS) -0.67
Full Income Statement

Balance Sheet

The company has 25.31M in cash and 54.8M in debt, giving a net cash position of -29.48M.

Cash & Cash Equivalents 25.31M
Total Debt 54.8M
Net Cash -29.48M
Retained Earnings -367.55M
Total Assets 75.5M
Working Capital 65.8M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -28.85M and capital expenditures 0, giving a free cash flow of -28.85M.

Operating Cash Flow -28.85M
Capital Expenditures 0
Free Cash Flow -28.85M
FCF Per Share -0.46
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

MIST does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for MIST is $9.5, which is 654% higher than the current price. The consensus rating is "Buy".

Price Target $9.5
Price Target Difference 654%
Analyst Consensus Buy
Analyst Count 2
Stock Forecasts

Scores

Altman Z-Score -6.94
Piotroski F-Score 2